Order Article Reprints

Pellacani G, Bigi L, Parodi A, Burlando M, Lanna C, Campione E, Rongioletti F, Mugheddu C, Malara G, Moretti G, et al. Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: DIMESKIN-2, a Multicentre Single-Arm Phase IIIb Study. Journal of Clinical Medicine. 2022; 11(16):4778. https://doi.org/10.3390/jcm11164778

Pellacani, Giovanni, Laura Bigi, Aurora Parodi, Martina Burlando, Caterina Lanna, Elena Campione, Franco Rongioletti, Cristina Mugheddu, Giovanna Malara, Giovanna Moretti, and et al. 2022. "Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: DIMESKIN-2, a Multicentre Single-Arm Phase IIIb Study" Journal of Clinical Medicine 11, no. 16: 4778. https://doi.org/10.3390/jcm11164778

Pellacani, G., Bigi, L., Parodi, A., Burlando, M., Lanna, C., Campione, E., Rongioletti, F., Mugheddu, C., Malara, G., Moretti, G., Stingeni, L., Hansel, K., Micali, G., Naldi, L., Pirro, F., & Peris, K. (2022). Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: DIMESKIN-2, a Multicentre Single-Arm Phase IIIb Study. Journal of Clinical Medicine, 11(16), 4778. https://doi.org/10.3390/jcm11164778